Role of soluble adenylyl cyclase in TSH biology
可溶性腺苷酸环化酶在 TSH 生物学中的作用
基本信息
- 批准号:9814720
- 负责人:
- 金额:$ 39.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAddressAdenylate CyclaseAffinityAnimal ModelBenignBicarbonatesBindingBiological AssayBiologyCREB1 geneCRISPR/Cas technologyCalciumCatalytic DomainCell NucleusCell ProliferationCellsCodeComplementComplexConcentration CampsCritical PathwaysCyclic AMPCyclic AMP-Dependent Protein KinasesCytoskeletonDataDiffusionDown-RegulationEndocrineEndocrine System DiseasesEngineeringFamilyFluorescence Resonance Energy TransferGTP-Binding Protein alpha Subunits, GsGTP-Binding ProteinsGeneticGoalsGrowthHormone secretionHormonesInfectionInjectionsIntegral Membrane ProteinInterventionLengthLightLinkMalignant NeoplasmsMalignant neoplasm of thyroidMass Spectrum AnalysisMediatingMembraneMethodsMusNuclearPathway interactionsPharmacologyPhosphorylationPositioning AttributeProteinsProteolysisProtocols documentationReagentReceptor SignalingRecording of previous eventsReportingResearchResistanceRoleScaffolding ProteinSecond Messenger SystemsSignal PathwaySignal TransductionSubfamily lentivirinaeSuspensionsTestingThyroid Function TestsThyroid GlandThyroid HormonesThyrotropin ReceptorTimeUltrasonographyViralbasecell growthclinically relevantepidemiology studygenetic approachgenetic regulatory proteininhibitor/antagonistknock-downmembermutantnanoluciferasenew therapeutic targetnoveloptogeneticsradixin proteinscaffoldsensorsmall hairpin RNAsynergismtherapeutic targettooltranscription factortumor progression
项目摘要
Thyroid cancer is the most common endocrine malignancy, with an alarmingly steady increase in the last few
years. Causal factors remain ill-defined. TSH is the major regulator of the thyroid gland involved in thyroid
growth, differentiation, and thyroid hormone secretion. Evidence from animal models and new epidemiological
studies suggest that TSH signaling pathways are critical for tumor progression. Thus, fully understanding the
mechanisms involved downstream of the TSHR might provide potential new targets for therapy.
TSH acts via the canonical TSHR-Gs-tmAC unit to synthesize cAMP, a second messenger mediating the
action of numerous hormones. tmACs are members of a large family of transmembrane proteins with a G-
protein-dependent adenylyl cyclase activity responsible for transducing membrane receptor signaling. Soluble
adenylyl cyclase (sAC), an evolutionarily conserved member of the adenylyl cyclase family, is a relatively
newly discovered activity not modulated by G-proteins, but instead activated by bicarbonate and calcium. The
premise of this proposal is based on the identification of a novel sAC/Cyclase-Associated Protein 1
(CAP1)/Rap1b complex. We will address its involvement in TSH biology in four integrated specific aims.
In Aim #1 we will utilize FRET-based cAMP sensors to assess whether pharmacological and genetic
(shRNA/CRISPR-Cas9) methods that interfere with sAC activity impact TSH-mediated cAMP levels;
preliminary data indicate sAC is involved in TSH-mediated cAMP dynamics regulating a PKA-PDE4 unit.
In Aim#2 we will assess the involvement of the sAC-CAP1 complex in TSH-mediated G1/S progression.
Pharmacological (sAC inhibitors) and genetic (sh-sAC/shCAP1) intervention inhibited TSH-mediated
proliferation. To assess a specific role for CAP1-associated sAC, we will use shRNA/CRISPR-Cas9
approaches to downregulate CAP1 in cells and we will perform rescue assays upon infection with lentivirus
coding for sh- or Cas9-resistant full length WT and mutant E171R-CAP1, deficient in sAC binding.
In Aim #3 we will address the involvement of a nuclear sAC pool in TSH-mediated G1/S progression. We will
use a newly developed optogenetic tool incorporating a blue-light activated cyclase (bPAC) fused to a blue-
emitting nanoluciferase (nLuc). Targeting the bPAC-nLuc construct to distinct compartments will allow us to
directly test whether cAMP generated in the nucleus is able to rescue proliferation upon sAC downregulation.
We will complement these cell studies by thyroid-specific deletion of sAC in mice and rescue mediated by
ultrasound-guided thyroid injection of compartment-specific sAC and bPAC-nLuc viral suspensions.
In Aim #4 we will exploit mass spectrometry approaches to identify new CAP1-associated proteins utilizing
newly developed reagents and optimized protocols for CAP1-pull down assays.
Our long-term goal is to provide mechanistic details underlying the novel sAC-CAP1-Rap1 complex and its
involvement in TSH biology.
甲状腺癌是最常见的内分泌恶性肿瘤,在过去的几年中有惊人的稳步上升。
好几年了。因果因素仍然定义不清。促甲状腺激素是甲状腺的主要调节器,与甲状腺有关。
生长、分化和甲状腺激素分泌。来自动物模型的证据和新的流行病学
研究表明,促甲状腺激素信号通路在肿瘤进展中起关键作用。因此,充分理解
TSHR下游的机制可能为治疗提供潜在的新靶点。
TSH通过经典的TSHR-Gs-TMAC单位合成cAMP,第二信使介导
多种荷尔蒙的作用。TmACs是一个跨膜蛋白大家族的成员,具有G-
负责转导膜受体信号的蛋白质依赖的腺酰环化酶活性。可溶的
腺酰环化酶(SAC)是腺酰环化酶家族中进化保守的成员,是一种相对保守的
新发现的活性不受G蛋白的调节,而是由碳酸氢盐和钙激活。这个
这一提议的前提是鉴定了一种新的SAC/环化酶相关蛋白1
(Cap1)/Rap1b复合体。我们将在四个综合的具体目标中解决它对TSH生物学的参与。
在目标1中,我们将使用基于FRET的cAMP传感器来评估药理学和遗传学
(shRNA/CRISPR-Cas9)干扰SAC活性的方法影响TSH介导的cAMP水平;
初步数据表明,SAC参与了TSH介导的cAMP动态调节PKA-PDE4单位。
在目标2中,我们将评估SAC-CAP1复合体在促甲状腺激素介导的G1/S进展中的作用。
药物(SAC抑制剂)和遗传(sh-SAC/shCAP1)干预抑制TSH介导的
扩散。为了评估CAP1相关SAC的特定作用,我们将使用shRNA/CRISPR-Cas9
下调细胞中Cap1的方法,我们将在感染慢病毒时进行救援检测
编码抗sh或Cas9的全长WT和突变体E171R-cap1,SAC结合缺陷。
在目标3中,我们将讨论核囊细胞池在促甲状腺激素介导的G1/S进展中的作用。我们会
使用一种新开发的光遗传工具,该工具将蓝光激活的环化酶(BPAC)融合到蓝色-
释放纳米荧光素酶(NLuc)。将bpac-nluc结构定位于不同的隔间将使我们能够
直接检测在胞核产生的cAMP是否能够在SAC下调时挽救增殖。
我们将在小鼠中通过甲状腺特异性缺失SAC来补充这些细胞研究,并通过
超声引导下甲状腺注射房室特异性SAC和BPAC-nLuc病毒悬液。
在目标#4中,我们将利用质谱学方法来鉴定新的cap1相关蛋白
用于cap1-down分析的新开发的试剂和优化的程序。
我们的长期目标是提供新的SAC-Cap1-Rap1复合体和它的
参与促甲状腺激素生物学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL L ALTSCHULER其他文献
DANIEL L ALTSCHULER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL L ALTSCHULER', 18)}}的其他基金
Novel mechanisms in the control of cAMP dynamics
控制 cAMP 动力学的新机制
- 批准号:
10733273 - 财政年份:2023
- 资助金额:
$ 39.13万 - 项目类别:
Role of soluble adenylyl cyclase in TSH biology
可溶性腺苷酸环化酶在 TSH 生物学中的作用
- 批准号:
10372085 - 财政年份:2019
- 资助金额:
$ 39.13万 - 项目类别:
Targeting Epac synergistic component in cAMP signaling
靶向 cAMP 信号传导中的 Epac 协同成分
- 批准号:
8796038 - 财政年份:2015
- 资助金额:
$ 39.13万 - 项目类别:
Targeting Epac synergistic component in cAMP signaling
靶向 cAMP 信号传导中的 Epac 协同成分
- 批准号:
9115657 - 财政年份:2015
- 资助金额:
$ 39.13万 - 项目类别:
Exploiting the cAMP pathway in Chagas Disease Therapy
在恰加斯病治疗中利用 cAMP 通路
- 批准号:
8147474 - 财政年份:2011
- 资助金额:
$ 39.13万 - 项目类别:
Exploiting the cAMP pathway in Chagas Disease Therapy
在恰加斯病治疗中利用 cAMP 通路
- 批准号:
8322695 - 财政年份:2011
- 资助金额:
$ 39.13万 - 项目类别:
Exploiting the cAMP pathway in Chagas Disease Therapy
在恰加斯病治疗中利用 cAMP 通路
- 批准号:
8515547 - 财政年份:2011
- 资助金额:
$ 39.13万 - 项目类别:
A Universal Mouse Line to Assess Tumor Clonality
用于评估肿瘤克隆性的通用小鼠系
- 批准号:
7106415 - 财政年份:2005
- 资助金额:
$ 39.13万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 39.13万 - 项目类别:
Research Grant